Nina Paleologos to DNA Modification Methylases
This is a "connection" page, showing publications Nina Paleologos has written about DNA Modification Methylases.
Connection Strength
0.055
-
A phase II study of bevacizumab and erlotinib after radiation and temozolomide in MGMT unmethylated GBM patients. J Neurooncol. 2016 Jan; 126(1):185-192.
Score: 0.034
-
Temozolomide single-agent chemotherapy for newly diagnosed anaplastic oligodendroglioma. J Neurooncol. 2009 Mar; 92(1):57-63.
Score: 0.021